- Home
- IMG vs ADXN Comparison
IMG vs ADXN Comparison
Compare IMG & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMG
- ADXN
- Stock Information
- Founded
- IMG 2011
- ADXN 2002
- Country
- IMG United States
- ADXN Switzerland
- Employees
- IMG N/A
- ADXN N/A
- Industry
- IMG
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- IMG
- ADXN Health Care
- Exchange
- IMG NYSE
- ADXN Nasdaq
- Market Cap
- IMG 7.2M
- ADXN 7.5M
- IPO Year
- IMG 2020
- ADXN N/A
- Fundamental
- Price
- IMG $0.66
- ADXN $7.60
- Analyst Decision
- IMG
- ADXN Strong Buy
- Analyst Count
- IMG 0
- ADXN 1
- Target Price
- IMG N/A
- ADXN $30.00
- AVG Volume (30 Days)
- IMG 639.9K
- ADXN 8.7K
- Earning Date
- IMG 05-27-2025
- ADXN 06-05-2025
- Dividend Yield
- IMG N/A
- ADXN N/A
- EPS Growth
- IMG N/A
- ADXN N/A
- EPS
- IMG N/A
- ADXN 0.06
- Revenue
- IMG $3,785,663.00
- ADXN $701,260.00
- Revenue This Year
- IMG $99.05
- ADXN N/A
- Revenue Next Year
- IMG $130.30
- ADXN N/A
- P/E Ratio
- IMG N/A
- ADXN $0.99
- Revenue Growth
- IMG 109.62
- ADXN N/A
- 52 Week Low
- IMG $0.25
- ADXN $6.51
- 52 Week High
- IMG $8.00
- ADXN $17.05
- Technical
- Relative Strength Index (RSI)
- IMG N/A
- ADXN 52.85
- Support Level
- IMG N/A
- ADXN $6.75
- Resistance Level
- IMG N/A
- ADXN $8.20
- Average True Range (ATR)
- IMG 0.00
- ADXN 0.46
- MACD
- IMG 0.00
- ADXN 0.06
- Stochastic Oscillator
- IMG 0.00
- ADXN 64.50
About IMG CIMG INC
CIMG Inc is a coffee and technologies company. The company is a co-packer of single-serve pour-over coffee, coffee brew bags and Dripkits. The company's brand portfolio includes Coffee Blenders, Twin Peaks, Active Cup, Relax Cup, Think Cup, Nude Cup, Pine Ranch Coffee, and Dripkit. Its geographical segments are North America, which accounts for the majority of revenue; and South Korea.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.